TOVX (Theriva Biologics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on TOVX (Theriva Biologics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

TOVX

Theriva Biologics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Theriva Biologics: Q3 Earnings Snapshot
Nov 12, 2025
Theriva Biologics Provides Response to Unusual Market Action
Oct 24, 2025
Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
Oct 16, 2025
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
Oct 13, 2025
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Oct 6, 2025
Theriva Biologics: Q2 Earnings Snapshot
Aug 11, 2025
Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results
May 14, 2025
Theriva Biologics: Q1 Earnings Snapshot
May 14, 2025
Theriva Biologics Announces Closing of $7.5 Million Public Offering
May 8, 2025
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
May 7, 2025
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
Apr 10, 2025
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Mar 31, 2025
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
Mar 19, 2025
Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
Mar 5, 2025

Reviews